Secondary Logo

Journal Logo

August 2013 - Volume 35 - Issue 4
pp: 417-556

Measuring Ribavirin Concentrations During the Earliest Stages of Antiviral Therapy for Hepatitis C: Potential Relevance for Treatment Outcome

van Vlerken, Lotte G.; de Kanter, Clara T.M.M.; Boland, Greet J.; More

Therapeutic Drug Monitoring. 35(4):546-551, August 2013.

Pharmacokinetic Study of Dual Therapy With Raltegravir 400 mg Twice Daily and Darunavir/Ritonavir 800/100 mg Once Daily in HIV-1–Infected Patients

Martínez-Rebollar, Maria; Muñoz, Ana; Pérez, Iñaki; More

Therapeutic Drug Monitoring. 35(4):552-556, August 2013.